Nanxin Pharmaceutical: Net loss of 40.02 million yuan in the first half of 2025.

Southern New Pharmaceutical announced that the operating income in the first half of 2025 was 61.8463 million yuan, a year-on-year decrease of 71.28%. The net loss was 40 million and 23 thousand yuan, while the net profit in the same period last year was 101.727 million yuan.